Chris Medlar

Chris Medlar currently serves as National Sales Director at SUN PHARMA, leading an Oncology Field Based team comprising 6 Directors and 24 Account Managers since October 2022. Previously, Chris held the National Sales Director position at Secura Bio, Inc., overseeing a team focused on rare diseases such as CLL and Follicular Lymphoma from July 2021 to October 2022. Prior to that, Chris facilitated the launch of the inaugural US Commercial team for Innate Pharma, specializing in ultra-rare Hairy Cell Leukemia, from August 2019 to July 2021. Chris also constructed a National Key Account Manager team at Kyowa Kirin, focusing on the launch of a rare disease therapy for Cutaneous T-Cell Lymphoma from December 2017 to August 2019. Chris's extensive experience further includes various roles at Amgen and Pfizer, emphasizing oncology and account management in significant healthcare settings. Education was completed at Penn State University.